Katherine Hobson
Investors were pleased that a CMS announcement didn’t suggest the question of whether or not Provenge should be covered is on the agenda.
Read more this great post here
Continued Read ...
MEwens
Mutations in the BRCA1 and BRCA2 genes raise the lifetime risk of breast cancer to as much as 84% and of ovarian cancer to as much as 63%.
Read more this great post here
Continued Read ...
Katherine Hobson
Also: experimental melanoma drug results; California insurance news; radiation at Walter Reed.
Read more this great post here
Continued Read ...
Katherine Hobson
Also: study quantifies radiation from nuclear imaging tests; Genzyme and Sanofi talk price; routine care coverage for clinical trial participants.
Read more this great post here
Continued Read ...
Katherine Hobson
Nobel Laureate Lee Hartwell on what’s on his plate after he retires as head of Fred Hutchinson Cancer Research Center this fall.
Read more this great post here
Continued Read ...
MEwens
It’s not totally clear what led to the increased survival among patients receiving palliative care alongside standard cancer treatment.
Read more this great post here
Continued Read ...
MEwens
Global health and cancer-care luminaries call for increased attention to cancer in lower-income countries.
Read more this great post here
Continued Read ...
MEwens
If the charges are true, it wouldn’t be the first time cancer patients were targeted by identity thieves.
Read more this great post here
Continued Read ...
MEwens
One study found that 63% of physicians were overly optimistic about how long their terminal patients would live.
Read more this great post here
Continued Read ...
MEwens
Today, the company reported its first ever revenue from the product — $2.8 million in the second quarter, plus an additional $5.2 million in July.
Read more this great post here
Continued Read ...